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Platelet-derived growth factor receptor (PDGFR) signaling is required for normal gastrulation in Xenopus laevis. Embryos deprived of
PDGFR signaling develop with a range of gastrulation-specific defects including spina bifida, shortened anteroposterior axis, and reduced
anterior structures. These defects arise because the involuting mesoderm fails to move appropriately. In this study, we determine that
inhibition of PDGFR signaling causes prospective head mesoderm cells to appear in the blastocoel cavity at the onset of gastrulation, stage
10. These aberrant cells undergo apoptosis via the caspase 3 pathway at an embryonic checkpoint called the early gastrula transition (EGT).
They are TUNEL-positive and have increased levels of caspase 3 activity compared to control embryos. Apoptotic death of these mesoderm
cells can be prevented by co-injection of mRNA encoding Bcl-2 or by injection of either a general caspase inhibitor or a caspase 3-specific
inhibitor. Prevention of cell death, however, is not sufficient to rescue gastrulation defects in these embryos. Based on these data, we propose
that PDGFR signaling is necessary for survival of prospective head mesoderm cells, and also plays an essential role in the control of their cell
movement during gastrulation.
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Platelet-derived growth factor receptor (PDGFR) signal-
ing is essential for normal embryonic development (reviewed
in Betsholtz et al., 2001; Hoch and Soriano, 2003). When
PDGFR signaling is disrupted during embryogenesis, the
embryos develop with severe abnormalities, often resulting
in death. For example, PDGFRa null mouse embryos die at
specific stages of development that are associated with
periods of cell movement and differentiation, such as neural
crest cell migration and organogenesis (Soriano, 1997).
Amphibian, sea urchin, zebrafish, and cow embryos are
similarly affected when they are deprived of PDGFR signal-
ing (Ataliotis and Mercola, 1997; Hoch and Soriano, 2003;
Liu et al., 2002). At the time of death, all of these embryos0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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failure of mesenchyme cells to migrate or differentiate.
Of the two PDGFRs (a and h) and four PDGF ligands
(A, B, C, and D), PDGFRa and PDGF-A are the predom-
inant forms present in the early embryo (Jones et al., 1993).
The receptors and ligands are generally expressed in sepa-
rate tissues that are brought into contact for the first time
through cell rearrangements. This pattern of expression is
reiterated throughout development in which motile cells
expressing PDGFR move across stationary cells expressing
PDGF ligands. For example, during gastrulation in frog and
mouse embryos, mesoderm cells expressing PDGFRa move
across ectoderm cells that express PDGF-A (Ataliotis et al.,
1995; Orr-Urtreger and Lonai, 1992). Later, during neural
crest cell migration in zebrafish, mice, and frogs, neural
crest cells expressing PDGFRa move through the branchial
arches that express PDGF-A and PDGF-C (Aase et al.,
2002; Ding et al., 2000; Ho et al., 1994; Liu et al., 2002;
Orr-Urtreger and Lonai, 1992; Soriano, 1997). Moreover,
during organogenesis, PDGFRs and their ligands tend to be
expressed in the mesenchymal and epithelial tissues, respec-
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(Aase et al., 2002; Betsholtz et al., 2001; Ding et al., 2000;
Orr-Urtreger and Lonai, 1992; Sun et al., 2000). In cells in
culture, PDGFR signaling also plays a role in cell motility
and is known to affect cellular processes important for it,
including rearrangement of the actin cytoskeleton, adhesion
to fibronectin, and chemotaxis (reviewed in Heldin et al.,
1998; Heldin and Westermark, 1999). Taken together, these
studies suggest that PDGFR signaling controls cell motility
and differentiation both in vivo and in vitro.
Inhibition of PDGFR signaling in Xenopus embryos
using a dominant inhibitory PDGFRa (PDGFR-37) results
in embryos with severe developmental defects including an
open blastopore, spina bifida, and reduced anterior struc-
tures (Ataliotis et al., 1995). These defects arise because the
cell movements of gastrulation are disrupted. During gas-
trulation, the first mesoderm cells to move into the embryo
are the presumptive head mesoderm cells (Keller and
Winklbauer, 1992). These cells migrate across a fibronectin
matrix that lines the inner surface of the blastocoel roof.
When PDGFR signaling is inhibited in Xenopus embryos,
the presumptive head mesoderm cells fail to adhere to the
blastocoel roof and accumulate in the blastocoel cavity. The
fate of these detached cells is unknown; however, it has been
suggested that they may simply die (Ataliotis et al., 1995).
During embryogenesis, a specific form of cell death,
called apoptosis, is used to shape tissues and organs and to
remove damaged cells in the developing embryo (Hensey
and Gautier, 1997, 1998; reviewed in Jacobson et al., 1997).
Apoptosis occurs through the activation of specific cysteine
proteases, termed caspases that lead to the disassembly of
the cell through the cleavage of proteins necessary for cell
integrity and survival (reviewed in Evan and Littlewood,
1998; Thornberry and Lazebnik, 1998). In Xenopus, apo-
ptosis is first detected at the beginning of gastrulation at a
checkpoint termed the early gastrula transition (EGT; Howe
et al., 1995). At the EGT, two classes of cells can die. First,
as part of normal development, a small percentage of
ectoderm cells undergoes apoptosis (Hensey and Gautier,
1998). Second, cells that received an apoptotic stimulus
much earlier in development, before the mid blastula tran-
sition (MBT), wait until the EGT to undergo apoptosis
(Hensey and Gautier, 1997; Howe et al., 1995; Stack and
Newport, 1997). In both cases, cell death occurs through the
mitochondrial apoptotic pathway. This pathway is regulated
by anti-apoptotic factors, such as Bcl-2 and pro-apoptotic
factors. Once the apoptotic pathway is triggered, a cascade
of signaling events leads to the activation of caspases 3 and
7 and the subsequent disassembly of the cell (Thornberry
and Lazebnik, 1998).
In this study, we determine that inhibition of PDGFR
signaling causes mesoderm cells to appear in the blastocoel
cavity at the onset of gastrulation, stage 10. These detached
cells undergo apoptosis via the mitochondrial pathway at
the EGT. They are TUNEL positive and have increased
levels of caspase 3 activity compared to control embryos.The death of these mesoderm cells is prevented by co-
injection of mRNA encoding Bcl-2 or by injection of a
general caspase inhibitor or a caspase 3-specific inhibitor.
Although these cells are rescued from death, it is not
sufficient to rescue gastrulation movements in these em-
bryos. In contrast, inhibition of PDGFR signaling in Keller
explants of the axial mesoderm neither prevents their
convergent extension nor affects their cell survival. Based
on these data, we propose that PDGFR signaling is needed
for the survival of prospective head mesoderm cells and
also plays a vital role in the control of their cell movement
during gastrulation.Materials and methods
Embryos
Xenopus embryos were fertilized in vitro, dejellied in 2%
cysteine, pH 7.8, and cultured in 10% Marc’s Modified
Ringer (0.1 MMR, Peng, 1991) at temperatures between
14jC and 23jC as previously described (Ataliotis et al.,
1995). Embryos were staged according to Nieuwkoop and
Faber (1967).
mRNA synthesis and microinjection
mRNA for microinjection was transcribed from template
DNAwith the mMessage mMachine kit (Ambion). Embryos
were microinjected in a solution of 3% Ficoll in 1 MMR
(Peng, 1991). At the 2- to 4-cell stage, embryos were
injected into the dorsoanterior marginal zone of each blas-
tomere with 100 pg mRNA encoding a dominant negative
(PDGFR-37) or control, frameshift (PDGFR-FS) PDGFRa.
In whole embryo experiments, as a lineage tracer and to
equalize the amount of total mRNA introduced into embry-
os, 100 pg to 1 ng mRNA encoding h-galactosidase (h-gal)
with a nuclear localization signal (h-gal-NLS) was co-
injected. In the explant experiments, 1 ng of Gap43-GFP
mRNAwas injected as a lineage tracer (the generous gift of
E.M. DeRobertis). For the rescue experiments, embryos
were injected at the 2- to 4-cell stage as described above,
but with the addition of either 1 ng mRNA encoding Bcl-2
or XPDGFRa. Caspase inhibitors, 100–400 AM z-DEVD-
fmk or z-VAD-fmk (Enzyme Systems Products), were
microinjected directly into the blastocoel cavity at stages
8 to 9. The embryos were stained for h-gal activity as
described previously (Ataliotis et al., 1995).
Microdissection
Open-faced Keller explants were dissected, cultured, and
analyzed as described previously (Tahinci and Symes,
2003). Briefly, the explants were dissected at stage 10.25
from embryos that had been microinjected at the 2-cell stage
in the dorsoanterior region (see above). Only explants with
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a coverslip bridge and cultured in 1 Danilchik’s for Amy
(DFA) at 14jC until stage 20. The explants were then
photographed in bright field and GFP for analysis. Finally,
the explants were fixed in MEMFA for 1 h at room
temperature and stored in methanol before TUNEL staining.
TUNEL staining
Whole-mount TUNEL staining of Xenopus embryos was
carried out using the In Situ Cell Death Detection Kit, POD
(Roche Molecular Biochemicals) with the protocol modified
as described by Hensey and Gautier (1997). Briefly, em-
bryos were fixed for 1 h in 4% paraformaldehyde in PBS at
room temperature. They were then blocked for 1 h in 3%
hydrogen peroxide in methanol, rinsed in PBS, and perme-
ablized in 0.1% Triton-X 100 in 0.1% sodium citrate for 30
min on ice. The embryos were rinsed in PBS and placed in
the TUNEL reaction mixture at 37jC overnight for nicked-
end labeling. As a positive control, permeablized embryos
were incubated with 2 units of DNase I (Promega) for 30
min at 37jC before the labeling reaction. The embryos were
rinsed in PBS, blocked with 20% goat serum in PBT, and
incubated overnight at 4jC with the Converter-POD solu-
tion (anti-fluorescein HRP conjugated antibody). Before
staining, the embryos were rinsed overnight in PBS. For
the chromogenic horseradish peroxidase reaction, the em-
bryos were transferred to DAB substrate in DAB buffer as
described by the manufacturer (Roche Molecular Biochem-
icals) for 30 min to 1 h. The reaction was stopped by the
addition of PBS.
Whole-mount TUNEL staining of Keller explants was
performed as described above for embryos, except for the
following changes. Before TUNEL staining, the explants
were rehydrated by rinsing with 90% methanol in PBS (vol/
vol), 75% methanol, 50%, methanol, 25% methanol, and
finally 1 PBS. In addition, TUNEL-positive, fluorescein-
labeled cells were viewed directly using a SV6-GFP Mi-
croscope (Zeiss).
h-gal- and TUNEL-stained embryos were embedded for
sectioning in JB-4 (Polysciences) and sectioned at 5–8 Am.
The sections were mounted and viewed on an Axiovert
LM35 Microscope (Zeiss).
Caspase 3 activity assay
At stages 10 and 11, uninjected embryos and embryos
that had been injected with 200 pg PDGFR-37 mRNA or
PDGFR-FS mRNA were frozen on dry ice. They were then
thawed on ice and homogenized in 15 mM Tris, pH 6.8. The
yolk was freon (1,1,2-trichlorotrifluoroethane, ICN)
extracted from the lysates as described (Evans and Kay,
1991). As a positive control for apoptosis, embryos were
cultured in 0.1 mg/ml cycloheximide in 0.1 MMR (Hen-
sey and Gautier, 1997), and lysates were prepared as
described above. The protein concentration of each samplewas determined (Bio-Rad DC Protein Assay) and equal
amounts of total protein were assayed in a 96-well plate.
Each well contained 50 Ag total protein, 200 nM of the
caspase 3 substrate Ac-DEVD-pNA (Calbiochem) with
caspase 3 Incubation Buffer from the Caspase 3 Activity
Assay (Roche Molecular Biochemicals). The plate was
incubated overnight at room temperature, and the absor-
bance at 405 nm was determined.Results
Rounded mesoderm cells appear in the blastocoel cavity at
the beginning of gastrulation when PDGFR signaling is
blocked
The role of PDGFR signaling during gastrulation in
Xenopus embryos was previously examined by over-expres-
sion of PDGFR-37, a dominant-negative Xenopus PDGFRa
(Ataliotis et al., 1995). When 50–200 pg PDGFR-37
mRNA is microinjected into the lateral marginal zone at
the 2- to 4-cell stage, the embryos develop with gastrulation-
specific defects including spina bifida and reduced anterior
structures (Ataliotis et al., 1995 and see Fig. 1C). When
examined at stage 11, it was found that the anterior
mesoderm failed to migrate across the blastocoel roof and
large cells collected on the floor of the blastocoel cavity.
These defects are rescued by over-expression of wild type
PDGFRa (Fig. 1D and Tables 1 and 2).
To examine when the mesoderm cells appear in the
blastocoel cavity and their subsequent fate, embryos were
co-injected with 200 pg mRNA encoding PDGFR-FS or
PDGFR-37 and 200 pg mRNA encoding h-gal containing a
nuclear localization signal (h-gal-NLS) and then fixed at
stages before (stage 9; see Figs. 1E, I) and throughout early
gastrulation (stages 10, 10 + and 10.5; see Figs. 1F–H, J–
L). These embryos were stained for h-gal activity, embed-
ded, and sectioned for analysis (see Materials and methods).
Before gastrulation, mesoderm cells that received either
PDGFR-FS (Fig. 1E) or PDGFR-37 (Fig. 1I) mRNA are in
the marginal zone and have distinct nuclear h-gal staining.
As soon as gastrulation begins (stage 10), 33% of PDGFR-
37-injected embryos have large cells with fragmented and
non-nuclear h-gal staining present at the site of involution of
the dorsoanterior mesoderm and in the blastocoel cavity
(Figs. 1J, M). This number increases to 81% at stage 10+
and 68% at stage 10.5 (Fig. 1M). The number of large cells
with non-nuclear h-gal staining in the blastocoel cavity of
these embryos is approximately 6 at stages 10 and 10+ and
16 at stage 10.5 (Fig. 1M). At all these stages, sibling
embryos injected with PDGFR-FS mRNA have normal
involuting mesoderm cells with distinct nuclear h-gal stain-
ing (compare Figs. 1F–H with J–K). Not all PDGFR-37-
injected cells appear in the blastocoel cavity. Many of these
cells are expelled from the embryo and accumulate under
the vitelline membrane (data not shown).
Fig. 1. Inhibition of PDGFR signaling causes mesoderm cells to accumulate in the blastocoel cavity at the beginning of gastrulation. Xenopus embryos co-
injected at the 2- to 4-cell stage with h-gal-NLS mRNA and one of the following mRNAs: (A, E–H) PDGFR-FS, (B) XPDGFRa, (C, I–L) PDGFR-37, or (D)
XPDGFRa/PDGFR-37 at a 10:1 ratio. Embryos are assessed at stages (A–D) 41, (E, I) 9, (F, J) 10, (G, K) 10+, and (H, L) 10.5. (A) PDGFR-FS- and (B)
XPDGFRa-injected embryos develop normally. (C) PDGFR-37-injected embryos develop with gastrulation-specific defects. An example of a normal, mild,
and severe phenotype is shown (C). (D) These defects are rescued by over-expression of wild-type XPDGFRa. (I –L) When assessed earlier in development,
mesoderm cells with diffuse h-gal staining are found to appear in the blastocoel cavity of PDGFR-37-injected embryos beginning at stage 10. (E–H) At all
stages, PDGFR-FS-injected embryos develop normally, and their mesoderm cells have nuclear h-gal staining. (M) The number of detached cells in the
blastocoel cavity at stages 10, 10+, and 10.5 was assessed. Error bars represent standard error.
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apoptosis that has been identified previously by diffuse h-
gal staining derived from a nuclear-localized h-gal (McCall
and Steller, 1998). The appearance of diffuse h-gal staining
in the detached mesoderm cells residing in the blastocoel
cavity suggests that they are undergoing apoptosis.
Inhibition of PDGFR signaling causes mesoderm cells to
die by apoptosis at the EGT
To determine whether inhibition of PDGFR signaling
induces apoptosis in mesoderm cells, embryos injected with
200 pg PDGFR-37 (Figs. 2C, D) or PDGFR-FS (Fig. 2B)
mRNA at the 2-cell stage were examined by whole-mountTUNEL staining throughout gastrulation (stages 9 to 11). As
a positive control for the TUNEL assay, uninjected embryos
were treated with DNase I to create nicked-ends in the DNA
before incubation with the TUNEL enzyme (Fig. 2A, see
Materials and methods). To view TUNEL staining, the
embryos were embedded and sectioned. Mesoderm cells
first stain TUNEL-positive at stage 10.5 in PDGFR-37-
injected embryos (data not shown) with an increase in
TUNEL-positive cells appearing by stage 11 (Figs. 2C,
D). Within the blastocoel cavity, smaller cells have punctate
TUNEL staining (Figs. 2C, D). The larger cells, however,
often have no visible TUNEL staining suggesting that the
DNA is fragmented or the nucleus is completely broken
down (Figs. 2C, D). Embryos injected with PDGFR-FS
Fig. 2. Inhibition of PDGFR induces apoptosis via the caspase 3 pathway at
gastrulation. Nicked DNA, an indicator of apoptosis, is visualized by
terminal-UTP-nicked-end labeling (TUNEL). (A) Uninjected embryos
treated with DNase I before TUNEL labeling have TUNEL-positive cells
around the embryos periphery. (B) PDGFR-FS-injected embryos do not
TUNEL-positive mesoderm cells. (C) PDGFR-37-injected embryos have
TUNEL-positive cells in the blastocoel cavity. (D) An enlargement TUNEL
positive cells within the square in C. Note in the blastocoel, small cells are
TUNEL-positive (black arrowheads) and large cells are not (red arrow-
heads). (E) Caspase 3 activity was assessed at stages 10 and 11. Uninjected
embryos (Con), embryos injected with PDGFR-37 (R-37) or PDGFR-FS
(FS) mRNA at the 2- to 4-cell stage, embryos treated with 0.1 mg/ml
cycloheximide (Chx) at the 32-cell stage. Note caspase 3 activity is
increased in PDGFR-37-injected embryos compared to uninjected or
PDGFR-FS-injected controls. Error bars represent standard error.
Table 1
Disruption of PDGFR signaling induces apoptosis of mesoderm cells
through the mitochondrial apoptotic pathway
Gastrula
Phenotypes (%) No dead cells Dead cells n
PDGFR-FS 98 0 129
XPDGFR 100 0 45
Bcl-2 100 0 33
PDGFR-37 30 68 199
XPDGFR/PDGFR-37 61 39 44
Bcl-2/PDGFR-37 71 27 77
PDGFR-37 + VAD 63 32 87
PDGFR-37 + DEVD 67 32 95
PDGFR-FS + VAD 100 0 64
PDGFR-FS + DEVD 100 0 66
Cell death is assessed by the presence of mesoderm cells with diffuse h-
galactosidase staining in the blastocoel cavity at stage 11 to 11.5. Note that
cell death in embryos deprived of PDGFR signaling is rescued by injection
of caspase inhibitors or mRNA encoding wild type XPDGFRa or Bcl-2.
The remaining percent of embryos died.
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In both PDGFR-37- and PDGFR-FS-injected embryos, a
small number of TUNEL-positive cells are found in the
ectoderm (Figs. 2B, C). This is consistent with previously
reported data showing that a small percentage of ectoderm
cells normally undergo apoptosis at these stages (Hensey
and Gautier, 1998). These data suggest that inhibition of
PDGFR signaling causes mesoderm but not ectoderm cells
to die by apoptosis.
TUNEL staining detects nicked DNA and thus does not
necessarily distinguish between apoptotic and necrotic cell
death (Gold et al., 1994). To verify that inhibition of
PDGFR signaling results in apoptosis of mesoderm cells,
caspase 3 activity was assessed in PDGFR-37-injected
embryos (Fig. 2E). A freon-extracted lysate derived from
crushed embryos that had been injected with 200 pg
PDGFR-37 or PDGFR-FS mRNA was incubated with the
caspase 3 substrate Ac-DEVD-pNA (Miyanaga et al., 2002).
As a positive control for caspase 3 activity, uninjected
embryos were cultured in 0.1 mg/ml cycloheximide to
induce apoptosis and treated in tandem with the injected
embryos (Hensey and Gautier, 1997). PDGFR-37-injected
and cycloheximide-treated embryos have approximately a 3-
fold increase in caspase 3 activity compared to that of
sibling uninjected or PDGFR-FS-injected embryos at stage
11 (Fig. 2E). These data suggest that disruption of PDGFR
signaling results in apoptosis of mesoderm cells at the EGT
and that it occurs through the mitochondrial-apoptotic
pathway.
Bcl-2 and caspase inhibitors protect mesoderm cells from
apoptosis but do not rescue cell movements when PDGFR
signaling is disrupted
It has been shown previously that the normal death of
ectoderm cells at the EGT can be rescued by over-expres-
sion of Bcl-2 (Yeo and Gautier, 2003) suggesting thatapoptosis occurs through the mitochondrial-apoptotic path-
way at this time. To determine if the gastrulation defects
seen in PDGFR-37-injected embryos result from mesoderm
cell death via this apoptotic pathway, we over-expressed
Bcl-2 in PDGFR-37-injected embryos. Embryos were co-
injected into both cells at the 2-cell stage with 2 ng Bcl-2
mRNA, 200 pg PDGFR-37 mRNA, and h-gal-NLS mRNA.
The presence of displaced cells in the blastocoel cavity with
diffuse or punctate h-gal staining at stages 11 to 11.5 was
Table 2
Prevention of cell death in PDGFR-37-injected embryos is not sufficient to
rescue gastrulation-specific defects
Tailbud
Gastrulation defects n
Normal Mild Severe
PDGFR-FS 76 15 1 179
XPDGFR 70 12 4 83
Bcl-2 61 24 10 119
PDGFR-37 20 23 48 271
XPDGFR/PDGFR-37 55 17 24 76
Bcl-2/PDGFR-37 14 32 44 194
PDGFR-37 + VAD 33 14 53 49
PDGFR-37 + DEVD 26 40 34 53
PDGFR-FS + VAD 82 18 0 39
PDGFR-FS + DEVD 82 16 2 38
Tailbud staged embryos (stage 26–38) are scored according to phenotype:
normal, mild or severe. Mild phenotype includes embryos with a slightly
shortened axis, bent axis, and ‘‘bubble belly’’. Severe phenotype includes
significantly shortened axis, spina bifida and reduced anterior structures.
The remaining percent of embryos died.
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10-fold excess of Bcl-2 to PDGFR-37 mRNA was able to
prevent mesoderm cell death (Table 1 and Fig. 3C). Sixty-
eight percent of PDGFR-37-injected embryos contained
cells with diffuse h-gal staining in the blastocoel cavity
(Table 1; Fig. 3B). This number was reduced to 27% when
Bcl-2 mRNA was co-injected with PDGFR-37 mRNA
(Table 1). In no instance did injection of Bcl-2 mRNA
alone cause mesoderm cells to die or appear in the blasto-
coel (Table 1). This rescue of cell death is similar to that
obtained when mRNA encoding wild type XPDGFRa is co-
injected with PDGFR-37 mRNA (Table 1). Cells rescued by
co-injection of Bcl-2 and PDGFR-37 mRNAs have distinct
nuclear h-gal staining (Fig. 3C). Taken together, these data
further support the hypothesis that inhibition of PDGFR
signaling leads to mesoderm cell death through the mito-
chondrial-apoptotic pathway.
Over-expression of Bcl-2 prevents the apoptosis of
mesoderm cells when PDGFR signaling is inhibited but it
does not rescue gastrulation defects in these embryos (Figs.
3F, I; Table 2). A low percentage (29%) of embryos co-
injected with Bcl-2 and PDGFR-37 mRNAs, however,
develop with abnormal lumps along the dorsal axis (Fig.
3F). These lumps are visible at the tailbud stage and containFig. 3. Over-expression of Bcl-2 in PDGFR-37-injected embryos rescues the ce
received mRNAs encoding h-gal-NLS and (A, D) PDGFR-FS, (G) Bcl-2, (B, E, H
stage were fixed and stained for h-gal at stages (A–C) 11 and (D–I) 26. Note the
injected embryos (B, arrows; a mild phenotype is shown—see Fig. 4 for sever
embryos (C) at stage 11. Also note the presence of lumps along the dorsal axis
Gastrula-staged embryos are oriented animal up, dorsoanterior right.h-gal staining, indicating that they are derived from cells
that received the injected mRNA (Fig. 3F). This ‘‘lump’’
phenotype is not seen in embryos co-injected with wild type
XPDGFRa and PDGFR-37 mRNAs (see Fig. 1D). It isll death but not gastrulation movements of mesoderm cells. Embryos that
) PDGFR-37, or (C, F, I) Bcl-2/PDGFR-37 at a 10:1 ratio at the 2- to 4-cell
presence of cells with diffuse h-gal staining in the blastocoel of PDGFR-37-
e PDGFR-37 phenotypes) and their absence in Bcl-2/PDGFR-37-injected
of Bcl-2/PDGFR-37-injected embryos at the tailbud stage (F, arrowheads).
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when PDGFR signaling is blocked, but rescued from death
by Bcl-2. The rescued cells are then presumably swept
along with involuting trunk mesoderm cells and subsequent-
ly end up in an inappropriate location. In support of thisFig. 4. Inhibition of caspases rescues cell death but not gastrulation movements
with mRNAs encoding h-gal NLS and (A–F) PDGFR-FS or (G–L) PDGFR-37
cavity was injected with 400 uM of (B, E, H, K) a general caspase inhibitor (z-V
were cultured until stage 11.5 or 28 before being fixed and stained for h-gal. Not
(A–C) and in the PDGFR-37-injected embryos, the rescue of cells with diffuse h-
injected embryos, however, still exhibit gastrulation defects at stage 28 (comparenotion, this lump phenotype is not seen when embryos are
injected with Bcl-2 mRNA alone (Fig. 3G). Injection of Bcl-
2 mRNA alone, however, does cause severe gastrulation
defects in a small percentage of embryos (10%; Table 2, and
Fig. 3G). These defects are most likely due to the rescue ofin PDGFR-37-injected embryos. Embryos were co-injected dorsoanteriorly
at the 2- to 4-cell stage. At the blastula stage (stages 8–9), the blastocoel
AD-fmk) or (C, F, I, L) a caspase 3 inhibitor (z-DEVD-fmk). The embryos
e, no h-gal-positive cells in the blastocoel of PDGFR-FS-injected embryos
gal staining by caspase inhibitors (compare G with H, I). Caspase inhibitor-
J with K, L). Cells with diffuse h-gal staining are indicated (arrows).
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sis (Hensey and Gautier, 1998; Yeo and Gautier, 2003).
A similar rescue of apoptosis, but not gastrulation, is
seen when caspase inhibitors are injected into the blastocoel
of PDGFR-37-injected embryos (Fig. 4). Embryos were
injected in both cells at the 2-cell stage with 200 pg
PDGFR-37 mRNA and cultured until the blastula stages
(stages 8 to 9). At this time, 400 AM of either the general
caspase inhibitor z-VAD-fmk or the caspase 3 inhibitor z-
DEVD-fmk was injected directly into the blastocoel cavity.
The embryos were then scored at stages 11 (Figs. 4A–C,
G–I) and 28 (Figs. 4D–F, J–L). Both caspase inhibitors
were able to rescue the death of mesoderm cells (Figs. 4 H
and I and Table 1) but not their gastrulation movements
(Figs. 4K, L and Table 2).
Taken together, these data show that apoptosis of meso-
derm cells resulting from disruption of PDGFR signaling
can be rescued by inhibition of the mitochondrial-apoptotic
pathway, but the normal migratory behavior of these cells is
not restored. This suggests that PDGFR signaling is not
simply a survival mechanism for mesoderm cells during
gastrulation but plays an essential role in the control of their
movement during gastrulation.Fig. 5. PDGFR signaling is not required for convergent extension of open-faced K
co-injected with Gap43-GFP and either PDGFR-FS or PDGFR-37 mRNAs (see
positive explants were fixed in MEMFA to quench the GFP fluorescence, and
PDGFR-FS-injected explants elongate to a similar extent as (D) PDGFR-37-injecte
TUNEL-positive, fluorescein-labeled, cells as (E, F) PDGFR-37-injected explants.
from three independent experiments are shown in A and D.PDGFR signaling is not required for convergent extension
of Keller explants
In Xenopus gastrulation, the prospective head mesoderm
cells actively migrate across the blastocoel roof whereas the
prospective axial mesoderm cells carry out a different type
of cell movement. These cells undergo mediolateral inter-
calation in a tissue rearrangement called convergent exten-
sion (Keller, 1991; Wallingford and Harland, 2002). In our
previous study, we examined the role of PDGFR signaling
in convergent extension in exogastrulae (Ataliotis et al.,
1995). These experiments suggested that PDGFR signaling
is not involved in convergent extension, since PDGFR-37-
injected exogastrulae elongate to a similar extent as control
embryos. To strengthen these data and to determine whether
deprivation of PDGFR signaling affects cell survival of the
axial mesoderm, convergent extension and apoptosis were
assessed in Keller explants (Fig. 5). Keller explants were
dissected at stage 10.25 from embryos that had been
injected with either PDGFR-FS or PDGFR-37 mRNA and
Gap43-GFP mRNA at the 2-cell stage in the dorsoanterior
marginal zone. The explants were cultured to stage 20 and
scored. No difference in elongation of PDGFR-37-injected
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Material and methods). The explants were cultured until stage 20. GFP-
subjected to TUNEL staining using dUTP conjugated to fluorescein. (A)
d explants. (B, C) PDGFR-FS-injected explants contain a similar number of
Examples of TUNEL-positive cells are indicated (arrowheads). The explants
M. Van Stry et al. / Developmental Biology 268 (2004) 232–242240explants versus control PDGFR-FS-injected explants was
observed (compare Figs. 5A, D). Furthermore, no difference
between TUNEL staining in PDGFR-37- and PDGFR-FS-
injected explants at stage 20 was detected (compare Figs.
5B, C with E, F. Note a similar and low number of TUNEL
positive—fluorescein-labeled—cells in Figs. 5B, C and E,
F). Taken together, these data suggest that PDGFR signaling
is not required for cell intercalation or survival of the axial
mesoderm but plays a significant role in motility and
survival of prospective head mesoderm cells.Discussion
In this study, we demonstrate that inhibition of PDGFR
signaling in Xenopus embryos leads to apoptosis in meso-
derm cells at the onset of gastrulation. The involuting
mesoderm cells normally express PDGFRa as they migrate
across the ectoderm that expresses PDGF-A (Ataliotis et al.,
1995). When PDGFR signaling is blocked in these cells,
they do not adhere to the blastocoel roof, fail to migrate,
and appear in the blastocoel cavity. These mesoderm cells
enter the mitochondrial-caspase 3 apoptotic pathway at the
early gastrula transition (EGT; Howe et al., 1995) when
embryos become competent to undergo programmed cell
death. This cell death can be prevented by over-expression
of the anti-apoptotic factor Bcl-2 or by caspase inhibitors.
However, the prevention of cell death is not sufficient to
prevent gastrulation defects, suggesting that PDGFR sig-
naling is not only serving as a survival factor, but also is
required for proper migration of these cells. In contrast,
cells of the prospective axial mesoderm can undergo
convergent extension and do not undergo apoptosis when
PDGFR signaling is blocked. This suggests that PDGF
signaling is less important for cell motility and survival of
the axial mesoderm than the prospective head mesoderm
during gastrulation.
Inhibition of PDGFR signaling results in death of
prospective head mesoderm cells
PDGFR signaling promotes cell survival both in vivo and
in a variety of cultured cells (reviewed in Heldin et al.,
1998). For example, apoptosis is triggered in vascular
endothelial cells in neonatal mice (Sano et al., 2002) and
fibroblasts (Brennand et al., 1997) when signaling via
PDGFRh and PDGF-BB are inhibited, respectively. Apo-
ptosis also occurs in the neural crest derived tissues of
PDGFRa null mice (Soriano, 1997). Initially reported in
PC12 cells (Yao and Cooper, 1995), PDGFR signaling has
been shown to promote cell survival through phosphatidy-
linositol 3-kinase (PI3K) and the anti-apoptotic kinase, Akt
(for reviews, see Datta and Greenberg, 1999; Bergmann,
2002). In response to PDGFR signaling, PI3K activates Akt,
which in turn phosphorylates the pro-apoptotic Bcl-2 family
member BAD. If phosphorylated, BAD protein becomesbound in an inactive complex and thus, cells are protected
from undergoing apoptosis. This pathway was recently
shown to also function in vivo. Using a knock-in strategy,
a mutant mouse was created in which BAD cannot be
phosphorylated (BAD3SA; Datta et al., 2002). Cells cultured
from these transgenic mice have a decreased rate of survival
even in the presence of PDGF.
The rescue of the apoptosis of Xenopus mesoderm cells
deprived of PDGFR signaling, however, is not sufficient to
restore their motility. This suggests that during gastrulation,
PDGFR signaling acts as more than a survival factor for
these cells. In support of this notion, PDGFR signaling has
been shown to affect a wide variety of behaviors in cells in
culture, in tissues and during embryogenesis including cell
motility, reorganization of the actin cytoskeleton, chemo-
taxis, and the control of cell division (for review, see
Betsholtz et al., 2001; Heldin and Westermark, 1999; Hoch
and Soriano, 2003). In Xenopus embryos, PDGFR signaling
through PI3K has been shown to induce spreading of
gastrula-staged mesoderm cells in culture (Symes and Mer-
cola, 1996) and appears to provide guidance cues for
prospective head mesoderm cells during gastrulation (T.
Nagel, E. Tahinci, K. Symes and R. Winklbauer, unpub-
lished observations). Likewise, PDGF signaling through
PI3K in zebrafish mesendoderm has been shown to induce
protrusions and polarization of the cells (Montero et al.,
2003). Also, upon PDGF treatment, PKB/Akt becomes
localized to the leading edge of the cells in a PI3K-
dependent manner (Montero et al., 2003).
PDGFR activation can stimulate several different signal-
ing pathways including those mediated by c-Src, Grb2, Grb
7, PI3K, phospholipase Cg (PLCg), RasGAP, and the
phosphotyrosine phosphatase Shp-2 (for review, see Heldin
and Westermark, 1999). It is therefore likely that multiple
signaling pathways are induced simultaneously and it is the
balance of their activities that defines PDGFR function in a
particular cell type. An example of this balance has been
reported in fibroblast cells. In this case, PDGFR induces
NFnB which in turn transmits two signals: one is required
for the induction of the proto-oncogene c-myc and prolifer-
ation and the other an anti-apoptotic signal that is transmit-
ted through the PI3K/Akt pathway and counterbalances c-
myc (Romashkova and Makarov, 1999). During gastrulation
in Xenopus embryos, PDGFR signaling likely induces an
anti-apoptotic signaling pathway and one or more additional
pathways important for cell motility.
PDGFR signaling does not control convergent extension of
Keller explants
Inhibition of PDGFR signaling in Keller explants of the
axial mesoderm neither prevents convergent extension nor
affects cell survival. This is perhaps because the majority of
axial mesoderm cells may not normally be subject to
PDGFR signaling in vivo. During Xenopus gastrulation,
while the prospective head mesoderm cells are in direct
M. Van Stry et al. / Developmental Biology 268 (2004) 232–242 241contact with ectoderm cells as they actively migrate across
the blastocoel roof, the axial mesoderm cells undergo
mediolateral intercalation within a tissue that is initially
several cell layers deep (Keller, 1991). Thus, prospective
axial mesoderm cells mostly do not appose the ectoderm,
the site of expression of PDGF-A (Ataliotis et al., 1995).
Additional signals may be necessary to induce apoptosis in
prospective head mesoderm cells deprived of PDGFR
signaling
Inhibition of PDGFR signaling alone may not be suffi-
cient to induce apoptosis in future head mesoderm cells.
Explants or dissociated single cells of Xenopus prospective
head mesoderm can be cultured on a fibronectin matrix in a
simple balanced salts solution that does not contain growth
factors, (Symes et al., 1994; Winklbauer and Keller, 1996;
Winklbauer and Nagel, 1991). These cells do not express
PDGF (Ataliotis et al., 1995), yet they do not die, are
actively motile, and can differentiate in vitro (Godsave
and Slack, 1991; Symes et al., 1994; Winklbauer and Keller,
1996; Winklbauer et al., 1996). In addition, explants of
Xenopus presumptive head mesoderm that have been dis-
sected from embryos in which PDGFR signaling has been
blocked can also migrate on fibronectin or a blastocoel roof
matrix (T. Nagel, E. Tahinci, K. Symes and R. Winklbauer,
unpublished observations). These data suggest that addi-
tional signals within the embryo may be necessary to initiate
apoptosis in embryos deprived of PDGFR signaling.
It is clear that environment directly affects cell activity.
For example, spatial organization is important for the
growth and adhesion of human mammary epithelial cells.
When organized in three-dimensional basement membrane
cultures, the signaling pathways that control growth and
adhesion of these cells are coupled and bi-directional. When
such cells are cultured as a two-dimensional, monolayer,
however, the same signaling pathways become uncoupled
(Wang et al., 1998). It is likely that in the embryo, signaling
pathways are similarly coupled and may account for the
differences in the survival of Xenopus presumptive head
mesoderm in situ and in vitro. The challenge now is to
identify the role of different signaling pathways acting
downstream of the PDGFR and to determine how these
pathways are coupled to control cell survival and motility
during gastrulation.Acknowledgments
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